DM
Deerfield Management’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-650,000
| Closed | -$7.53M | – | 108 |
|
|
2023
Q1 | $7.53M | Buy |
+650,000
| New | +$7.53M | 0.17% | 77 |
|
|
2022
Q4 | – | Sell |
-2,021,000
| Closed | -$11.7M | – | 116 |
|
|
2022
Q3 | $11.7M | Buy |
+2,021,000
| New | +$11.7M | 0.23% | 76 |
|
|
2021
Q2 | – | Sell |
-468,000
| Closed | -$15.6M | – | 153 |
|
|
2021
Q1 | $15.6M | Sell |
468,000
-107,000
| -19% | -$3.56M | 0.33% | 83 |
|
|
2020
Q4 | $14.9M | Buy |
+575,000
| New | +$14.9M | 0.29% | 84 |
|
|
2016
Q3 | – | Sell |
-63,072
| Closed | -$444K | – | 100 |
|
|
2016
Q2 | $444K | Buy |
+63,072
| New | +$444K | 0.02% | 102 |
|
|
2016
Q1 | – | Sell |
-1,388,000
| Closed | -$18.2M | – | 111 |
|
|
2015
Q4 | $18.2M | Sell |
1,388,000
-797,771
| -36% | -$10.5M | 0.74% | 46 |
|
|
2015
Q3 | $8M | Buy |
2,185,771
+699,910
| +47% | +$2.56M | 0.31% | 74 |
|
|
2015
Q2 | $8.56M | Sell |
1,485,861
-1,562,449
| -51% | -$9M | 0.29% | 75 |
|
|
2015
Q1 | $17.8M | Sell |
3,048,310
-2,072,461
| -40% | -$12.1M | 0.58% | 45 |
|
|
2014
Q4 | $40.1M | Buy |
5,120,771
+721,439
| +16% | +$5.66M | 1.44% | 22 |
|
|
2014
Q3 | $21.6M | Sell |
4,399,332
-295,871
| -6% | -$1.45M | 0.79% | 39 |
|
|
2014
Q2 | $29M | Sell |
4,695,203
-710,907
| -13% | -$4.39M | 1.17% | 23 |
|
|
2014
Q1 | $28.9M | Buy |
5,406,110
+1,054,848
| +24% | +$5.64M | 1.18% | 26 |
|
|
2013
Q4 | $22.8M | Sell |
4,351,262
-533,106
| -11% | -$2.79M | 1.18% | 28 |
|
|
2013
Q3 | $27M | Hold |
4,884,368
| – | – | 1.25% | 31 |
|
|
2013
Q2 | $12.4M | Buy |
+4,884,368
| New | +$12.4M | 0.58% | 55 |
|